108 related articles for article (PubMed ID: 14732590)
1. A rare polymorphism affects a mitogen-activated protein kinase site in synapsin III: possible relationship to schizophrenia.
Porton B; Ferreira A; DeLisi LE; Kao HT
Biol Psychiatry; 2004 Jan; 55(2):118-25. PubMed ID: 14732590
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of the synapsin III gene on chromosome 22q12-q13 in schizophrenia.
Ohtsuki T; Ichiki R; Toru M; Arinami T
Psychiatry Res; 2000 Apr; 94(1):1-7. PubMed ID: 10788672
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the promoter and coding regions of the synapsin III gene. A lack of association with schizophrenia.
Imai K; Harada S; Kawanishi Y; Tachikawa H; Okubo T; Suzuki T
Neuropsychobiology; 2001; 43(4):237-41. PubMed ID: 11340362
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of synapsin III gene in schizophrenia.
Tsai MT; Hung CC; Tsai CY; Liu MY; Su YC; Chen YH; Hsiao KJ; Chen CH
Am J Med Genet; 2002 Jan; 114(1):79-83. PubMed ID: 11840510
[TBL] [Abstract][Full Text] [Related]
5. A third member of the synapsin gene family.
Kao HT; Porton B; Czernik AJ; Feng J; Yiu G; Häring M; Benfenati F; Greengard P
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4667-72. PubMed ID: 9539796
[TBL] [Abstract][Full Text] [Related]
6. Synapsin III gene polymorphisms and schizophrenia.
Ohmori O; Shinkai T; Hori H; Kojima H; Nakamura J
Neurosci Lett; 2000 Jan; 279(2):125-7. PubMed ID: 10674637
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation by PKA and Cdk5 Mediates the Early Effects of Synapsin III in Neuronal Morphological Maturation.
Piccini A; Perlini LE; Cancedda L; Benfenati F; Giovedì S
J Neurosci; 2015 Sep; 35(38):13148-59. PubMed ID: 26400944
[TBL] [Abstract][Full Text] [Related]
8. Bidirectional changes in synapsin I phosphorylation at MAP kinase-dependent sites by acute neuronal excitation in vivo.
Yamagata Y; Jovanovic JN; Czernik AJ; Greengard P; Obata K
J Neurochem; 2002 Mar; 80(5):835-42. PubMed ID: 11948247
[TBL] [Abstract][Full Text] [Related]
9. Association between Synapsin III gene promoter polymorphisms and multiple sclerosis.
Liguori M; Cittadella R; Manna I; Valentino P; La Russa A; Serra P; Trojano M; Messina D; Ruscica F; Andreoli V; Romeo N; Livrea P; Quattrone A
J Neurol; 2004 Feb; 251(2):165-70. PubMed ID: 14991350
[TBL] [Abstract][Full Text] [Related]
10. Linkage and family-based association study of schizophrenia and the synapsin III locus that maps to chromosome 22q13.
Stöber G; Meyer J; Nanda I; Wienker TF; Saar K; Knapp M; Jatzke S; Schmid M; Lesch KP; Beckmann H
Am J Med Genet; 2000 Jun; 96(3):392-7. PubMed ID: 10898920
[TBL] [Abstract][Full Text] [Related]
11. Association of schizophrenia in African Americans to polymorphism in synapsin III gene.
Lachman HM; Stopkova P; Rafael MA; Saito T
Psychiatr Genet; 2005 Jun; 15(2):127-32. PubMed ID: 15900227
[TBL] [Abstract][Full Text] [Related]
12. An analysis of synapsin II, a neuronal phosphoprotein, in postmortem brain tissue from alcoholic and neuropsychiatrically ill adults and medically ill children and young adults.
Grebb JA; Greengard P
Arch Gen Psychiatry; 1990 Dec; 47(12):1149-56. PubMed ID: 2147098
[TBL] [Abstract][Full Text] [Related]
13. Analysis of synapsin III-196 promoter mutation in schizophrenia and bipolar disorder.
Lachman HM; Stopkova P; Papolos DF; Pedrosa E; Margolis B; Aghalar MR; Saito T
Neuropsychobiology; 2006; 53(2):57-62. PubMed ID: 16511335
[TBL] [Abstract][Full Text] [Related]
14. Activators of protein kinase C increase the phosphorylation of the synapsins at sites phosphorylated by cAMP-dependent and Ca2+/calmodulin-dependent protein kinase in the rat hippocampal slice.
Browning MD; Dudek EM
Synapse; 1992 Jan; 10(1):62-70. PubMed ID: 1311130
[TBL] [Abstract][Full Text] [Related]
15. Neurotrophins stimulate phosphorylation of synapsin I by MAP kinase and regulate synapsin I-actin interactions.
Jovanovic JN; Benfenati F; Siow YL; Sihra TS; Sanghera JS; Pelech SL; Greengard P; Czernik AJ
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3679-83. PubMed ID: 8622996
[TBL] [Abstract][Full Text] [Related]
16. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia.
Numakawa T; Yagasaki Y; Ishimoto T; Okada T; Suzuki T; Iwata N; Ozaki N; Taguchi T; Tatsumi M; Kamijima K; Straub RE; Weinberger DR; Kunugi H; Hashimoto R
Hum Mol Genet; 2004 Nov; 13(21):2699-708. PubMed ID: 15345706
[TBL] [Abstract][Full Text] [Related]
17. The gene for synapsin III and attention-deficit hyperactivity disorder.
Makkar R; Gomez L; Wigg KG; Ickowicz A; Pathare T; Tannock R; Malone M; Kennedy JL; Schachar R; Barr CL
Psychiatr Genet; 2007 Apr; 17(2):109-12. PubMed ID: 17413450
[TBL] [Abstract][Full Text] [Related]
18. Norepinephrine and isoproterenol increase the phosphorylation of synapsin I and synapsin II in dentate slices of young but not aged Fisher 344 rats.
Parfitt KD; Hoffer BJ; Browning MD
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2361-5. PubMed ID: 1900942
[TBL] [Abstract][Full Text] [Related]
19. Family-based association study of synapsin II and schizophrenia.
Chen Q; He G; Qin W; Chen QY; Zhao XZ; Duan SW; Liu XM; Feng GY; Xu YF; St Clair D; Li M; Wang JH; Xing YL; Shi JG; He L
Am J Hum Genet; 2004 Nov; 75(5):873-7. PubMed ID: 15449241
[TBL] [Abstract][Full Text] [Related]
20. Positive association between synapsin II and schizophrenia.
Chen Q; He G; Wang XY; Chen QY; Liu XM; Gu ZZ; Liu J; Li KQ; Wang SJ; Zhu SM; Feng GY; He L
Biol Psychiatry; 2004 Aug; 56(3):177-81. PubMed ID: 15271586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
